Alzheimer’s disease, which accounts for the majority of dementia cases, has long been considered “incurable,”
with a prevailing belief that even early detection and treatment could only slow its progression—eventually leading to a bedridden state within a few years.

Recently, a study involving 38 research institutions including the University of Tokyo was published in an American scientific journal.
It reported that 60% of Japanese individuals diagnosed with Mild Cognitive Impairment (MCI)—a pre-dementia stage—progress to full dementia within three years.
This means that even if MCI is identified, more than half of patients may still develop dementia in a short time span.
Despite ongoing efforts, no fundamental cure for dementia has yet been found.
This reality has contributed to the commonly held view that "once you develop dementia, there is no way to recover."

However, a groundbreaking treatment approach is now challenging this belief. The "ReCODE Protocol," developed by Dr. Dale Bredesen, a world-renowned authority on neurodegenerative diseases,
has generated global attention for claims such as “90% symptom improvement” and “over 500 patients recovered.”
His best-selling book, *The End of Alzheimer’s*, has also been published in Japanese and has sparked much interest in Japan.

I served as the supervising editor for the Japanese edition of this book.
The findings and perspectives presented strongly resonate with the results of my own research,
which has focused since 1990 on identifying the reasons behind the dramatic rise in Alzheimer’s and dementia cases over the past three decades.
Dr. Bredesen’s classification of 36 distinct contributing factors to Alzheimer’s is a major scientific achievement
that reinforces the validity of various therapeutic programs from a medical standpoint.

At our clinic, we implement a ReCODE-based detoxification protocol along with functional brainwave testing and other advanced diagnostic methods.
Through a close collaboration with Dr. Luis Aguilar and his team at the LIVANT Neuro Recovery Center in Mexico,
we provide supplement-based treatment guided by detailed functional EEG analysis.

We have seen measurable improvements not only in early-onset Alzheimer’s disease, but also in patients with:
dementia, vascular dementia, Lewy body dementia, frontotemporal dementia, Parkinson’s disease,
depression, autism spectrum disorder, schizophrenia, Asperger’s syndrome, ADHD,
post-stroke complications, and post-traumatic brain injury.

Dementia can be treated. It can be prevented. This is no longer a distant hope—it is becoming a reality.

At our clinic, Dr. Takuji Shirasawa—who has dedicated many years to dementia research—provides outpatient consultations
offering expert diagnostic testing, personalized treatment programs, and guidance for improving daily lifestyle habits as early as possible.

We sincerely hope to help enhance the quality of life for each patient and their families.

For more information, please refer to the following publication, which details our clinic's dementia prevention and treatment programs: